Analysis of full and partial agonists binding toβ2‐adrenergic receptor suggests a role of transmembrane helix V in agonist‐specific conformational changes
- 2 June 2009
- journal article
- research article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 22 (4) , 307-318
- https://doi.org/10.1002/jmr.949
Abstract
The 2.4 Å crystal structure of theβ2‐adrenergic receptor (β2AR) in complex with the high‐affinity inverse agonist (−)‐carazolol provides a detailed structural framework for the analysis of ligand recognition by adrenergic receptors. Insights into agonist binding and the corresponding conformational changes triggering G‐protein coupled receptor (GPCR) activation mechanism are of special interest. Here we show that while the carazolol pocket captured in theβ2AR crystal structure accommodates (−)‐isoproterenol and other agonists without steric clashes, a finite movement of the flexible extracellular part of TM‐V helix (TM‐Ve) obtained by receptor optimization in the presence of docked ligand can further improve the calculated binding affinities for agonist compounds. Tilting of TM‐Ve towards the receptor axis provides a more complete description of polar receptor–ligand interactions for full and partial agonists, by enabling optimal engagement of agonists with two experimentally identified anchor sites, formed by Asp113/Asn312 and Ser203/Ser204/Ser207 side chains. Further, receptor models incorporating a flexible TM‐V backbone allow reliable prediction of binding affinities for a set of diverse ligands, suggesting potential utility of this approach to design of effective and subtype‐specific agonists for adrenergic receptors. Systematic differences in capacity of partial, full and inverse agonists to induce TM‐V helix tilt in theβ2AR model suggest potential role of TM‐V as a conformational “rheostat” involved in the whole spectrum ofβ2AR responses to small molecule signals. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 54 references indexed in Scilit:
- Identifying conformational changes of the β2 adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulatorsJournal of Computer-Aided Molecular Design, 2009
- Structure of a β1-adrenergic G-protein-coupled receptorNature, 2008
- A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic ReceptorStructure, 2008
- Conformational changes in G‐protein‐coupled receptors—the quest for functionally selective conformations is openBritish Journal of Pharmacology, 2008
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled ReceptorScience, 2007
- Role of group-conserved residues in the helical core of β 2 -adrenergic receptorProceedings of the National Academy of Sciences, 2007
- G protein coupled receptor structure and activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94Journal of Computational Chemistry, 1996
- Residues in the Fifth Membrane-Spanning Segment of the Dopamine D2 Receptor Exposed in the Binding-Site CreviceBiochemistry, 1995
- Site-directed mutagenesis of the human dopamine D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992